Pathogenesis and management of HIV/TB co-infection in Asia

Tuberculosis

Volumn 87, Issue SUPPL. 1, 2007, Pages

  Goldfeld, Anne ^a,b   Ellner, Jerrold J ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b The Cambodian Health Committee ^*  (Cambodia)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Atypical forms; Integrated control and research programs in Cambodia; TB HIV; Vietnam

Indexed keywords

EFAVIRENZ; RIFAMPICIN;

ASIA; CAMBODIA; CD4+ T LYMPHOCYTE; CELL COUNT; COMMUNITY ASSESSMENT; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SMEAR; TUBERCULOSIS; VIET NAM; VIRUS REPLICATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; CAMBODIA; HIV; HIV INFECTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; VIETNAM;

EID: 34547655415     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2007.05.003     Document Type: Review

References (30)

1. Havlir D.V., and Barnes P.F. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 340 (1999) 367-373
2. Corbett E.L., Marston B., Churchyard G.J., and De Cock K.M. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367 (2006) 926-937
3. Toossi Z. Virologic and immunologic impact of tuberculosis on human immunodeficiency virus type 1 disease. J Infect Dis 188 (2003) 1146-1155
4. Thim S., Sath S., Sina M., Tsai E.Y., Delgado J.C., Shapiro A.E., et al. A community-based tuberculosis program in Cambodia. JAMA 292 (2004) 566
5. Goldfeld A.E., Delgado J.C., Thim S., Bozon M.V., Uglialoro A.M., Turbay D., et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 279 (1998) 226-228
6. Boussiotis V.A., Tsai E.Y., Yunis E.J., Thim S., Delgado J.C., Dascher C.C., et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 105 (2000) 1317-1325
7. Delgado J.C., Tsai E.Y., Thim S., Baena A., Boussiotis V.A., Reynes J.M., et al. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci USA 99 (2002) 7576-7581
8. Delgado J.C., Quinones-Berrocal J., Thim S., Miranda L.F., and Goldfeld A.E. Diagnostic and clinical implications of response to tuberculin in two ethnically distinct populations from Peru and Cambodia. Int J Tuberc Lung Dis 8 (2004) 982-987
9. Ranjbar S., Ly S., Thim S., Reynes J.M., and Goldfeld A.E. Mycobacterium tuberculosis recall antigens suppress HIV-1 replication in anergic donor cells via CD8+ T cell expansion and increased IL-10 levels. J Immunol 172 (2004) 1953-1959
10. Delgado J.C., Baena A., Thim S., and Goldfeld A.E. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 186 (2002) 1463-1468
11. Delgado J.C., Baena A., Thim S., and Goldfeld A.E. Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia. J Immunol 176 (2006) 1090-1097
12. Bell J.I., Todd J.A., and McDevitt H. The molecular basis of HLA-disease association. Adv Hum Genet 18 (1989) 1-41
13. Am J Respir Crit Care Med 167 (2003) 603-662
14. Kohrenromp A.L., Scano F., Williams B.G., Dye C., and Nunn P. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis 37 (2003) 101-112
15. de Jong B.C., Israelski D.M., Corbett E.L., and Small S.M. Clinical management of tuberculosis in the context of HIV infection. Ann Rev Med 55 (2004) 283-301
16. Fitzgerald D.W., Desvarieux M., Severe P.J., Johnson Jr. W.D., and Pape J.W. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet 356 (2000) 1470-1474
17. Churchyard G.J., Fielding K., Charalambous S., Day J.H., Corbett E.L., Hayes R.J., et al. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?. AIDS 17 (2003) 2063-2070
18. Sonnenberg P., Murray J., Glynn J.R., Shearer S., Kambashi B., and Godfery-Faussett. HIV-1 and recurrence, relapse, and re-infection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 358 (2001) 1687-1693
19. Ribera E., Azuaje C., Lopez R.M., Domingo P., Soriano A., Pou L., et al. Once-daily regimen of Saquinavir, Ritonavir, Didanosine and Lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study). J Acquir Immune Defic Syndr 40 (2005) 317-323
20. Manosuthi W., Kiertiburanakul S., Sungkanuparph S., Ruxrungtham K., Vibhagool A., Rattanasiri S., et al. Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampin: 48 weeks results. AIDS 20 (2006) 131-132
21. Ramachandran G., Hemanthkumar A.K., Rajasekaran S., Padmapriyadarsini C., Narendran G., Sukumar B., et al. J Acquir Immune Defic Syndr 42 (2006) 36-41
22. Narita M., Ashkin D., Hollender E.S., and Pitchenik A.E. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158 (1998) 157-161
23. Breton G., Duval X., Estellat C., Poaletti X., Bonnet D., Myondo Myondo D., et al. Determinants of the immune reconstitution inflammatory syndrome in HIV type I-infected patients with tuberculosis after initiation of antiretroviral syndrome. Clin Infect Dis 29 (2004) 1707-1712
24. Bouragit A., Carcelian G., Martininez V., Lascoux C., Delcey V., Gicquel B., et al. Explosion of tuberculin-specific Th1- responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 20 (2006) F1-F7
25. Dean G.L., Edwards S.G., Ives N.J., Matthews G., Fox E.F., Navaratne L., et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 16 (2002) 75-83
26. Antonucci GE, Vanacore P, Palmieri F, Matteeli A, Lemoli E, Carradori S, et al. Eur Resdpir J 24:11-7.
27. Harries A.D. Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource poor settings. Lancet 367 (2006) 944-945
28. Johnson J.L., Okwera O., Hom D.L., Mayanja H., Kityo C.M., Nsubuga P., et al. Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS 15/16 (2001) 2137-2147
29. Grant A.D., Charalambous S., Fielding K.L., Day J.H., Corbett E.L., Chaisson R.E., et al. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa. JAMA 293 (2005) 2719-2725
30. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: ac cohort study.